Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-27 @ 12:52 AM
Study NCT ID:
NCT05630066
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2022-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-09
First Submit QC Date:
None
Study First Post Date:
2022-11-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED